Histrelin
Protein
Overview
Histrelin is a protein active pharmaceutical ingredient (ChEMBL CHEMBL1201255).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Histrelin expires 16 Jun 2026. Generic API sourcing typically opens up once these lapse.
Chemical identity
- Canonical SMILES
- CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CN(C=N2)CC3=CC=CC=C3)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8
- InChIKey
- HHXHVIJIIXKSOE-QILQGKCVSA-N
Verified Supplier Partner
Do you supply Histrelin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.